Total Leucocytes Count

Blood

Report in 4Hrs

At Home

No Fasting Required

Details

Measures the total number of white blood cells (WBCs) in a given volume of blood

₹89₹110

19% OFF

Total Leucocytes Count - Comprehensive Medical Guide

Why is it done?
- Measures the total number of white blood cells (leucocytes/leukocytes) per microliter or liter of blood to assess immune system function and detect potential infections or blood disorders
- Primary indications include: suspicion of infection (bacterial, viral, fungal), diagnosis of leukemia and other blood cancers, monitoring immune system status, evaluation of fever of unknown origin, and assessment of bone marrow function
- Performed as part of routine health check-ups, complete blood count (CBC), pre-operative assessment, monitoring patients on immunosuppressive therapy, and during evaluation of symptoms like fever, fatigue, unexplained weight loss, or recurrent infections
- Commonly ordered in emergency departments, during hospital admission, in immunocompromised patients, and when evaluating inflammatory or malignant conditions
Normal Range
- Standard normal range in adults: 4,500 to 11,000 cells per microliter (cells/μL) or 4.5 to 11.0 × 10⁹ cells per liter (cells/L)
- Pediatric reference ranges vary by age: Newborns (9,000-30,000 cells/μL), infants (5,000-21,000 cells/μL), children aged 1-5 years (5,000-15,000 cells/μL), children aged 5-12 years (4,500-13,500 cells/μL)
- Results classified as: Low (Leukopenia) - below 4,500 cells/μL indicating immune suppression; Normal - 4,500-11,000 cells/μL indicating healthy immune function; High (Leukocytosis) - above 11,000 cells/μL indicating infection, inflammation, or malignancy
- Borderline elevation (11,000-15,000 cells/μL) may suggest mild stress response or early infection, while marked elevation (>25,000 cells/μL) indicates severe infection, leukemia, or acute inflammatory process
- Measurements performed using automated hematology analyzers; results reported in cells/μL or cells/L depending on laboratory protocol; reference ranges may vary slightly between laboratories due to different equipment and methodologies
Interpretation
- Elevated TLC (Leukocytosis >11,000 cells/μL): Indicates acute or chronic infection, leukemia, acute leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, leukemoid reaction to stress or inflammation, autoimmune diseases, allergic reactions, malignancies, tissue necrosis (myocardial infarction), corticosteroid use, or physical/emotional stress
- Decreased TLC (Leukopenia <4,500 cells/μL): Indicates bone marrow suppression or failure, severe infections overwhelming the immune system, aplastic anemia, HIV/AIDS, autoimmune conditions like lupus and rheumatoid arthritis, chemotherapy or radiation effects, nutritional deficiencies (folate, B12, copper), medications (antibiotics, NSAIDs, antithyroid drugs), splenomegaly, sepsis, or congenital immune deficiencies
- Mild elevation (11,000-15,000 cells/μL): May indicate early-stage infection, stress response, or minor inflammatory process; often requires correlation with clinical symptoms and differential count
- Marked elevation (>25,000 cells/μL): Highly suggestive of acute leukemia, severe bacterial infection, or significant leukemoid reaction; requires immediate further investigation and specialist consultation
- Factors affecting interpretation: Time of day (counts higher in evening), menstrual cycle, pregnancy, age, altitude, smoking status, medications, stress levels, recent vaccination, circadian rhythm variations, sample collection technique, and time delay between collection and analysis
- Clinical significance: TLC trends over time are more meaningful than single values; serial measurements help assess treatment response, disease progression, and bone marrow recovery; differential count (percentage of each leucocyte type) provides additional diagnostic information
Associated Organs
- Primary organ systems involved: Bone marrow (production site of leucocytes), lymphoid tissues (lymph nodes, spleen, thymus), immune system (function and response), liver (stores and processes blood cells), and kidneys (affected in systemic infections)
- Bone marrow disorders: Aplastic anemia, myelodysplastic syndromes, acute and chronic leukemias, multiple myeloma, lymphomas, and bone marrow infiltrative processes
- Infectious diseases: Bacterial infections (pneumonia, abscess, UTI), viral infections (influenza, COVID-19, HIV), fungal infections (candidiasis, aspergillosis), tuberculous infections, sepsis, and parasitic infestations
- Autoimmune and inflammatory diseases: Systemic lupus erythematosus (SLE), rheumatoid arthritis, Crohn's disease, ulcerative colitis, sarcoidosis, and vasculitis
- Hematologic malignancies: Acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and Hodgkin/non-Hodgkin lymphomas
- Splenic disorders: Splenomegaly from various causes leads to leukopenia due to sequestration of blood cells
- Potential complications of abnormal counts: Leukocytosis may cause hyperviscosity syndrome, thrombosis, and leukostasis; severe leukopenia increases risk of opportunistic infections, sepsis, and disseminated infections leading to multi-organ failure
Follow-up Tests
- Differential leucocyte count (DLC): Breaks down white cells into neutrophils, lymphocytes, monocytes, eosinophils, and basophils to identify specific types of elevation or reduction; essential for interpreting abnormal TLC
- Peripheral blood smear: Microscopic examination to visualize cell morphology, assess for abnormal cells (blasts, atypical lymphocytes), immature forms, or dysplasia; helps identify hematologic malignancies
- Complete blood count (CBC) with platelet count and hemoglobin: Provides comprehensive blood cell assessment; anemia or thrombocytopenia may accompany TLC abnormalities
- Bone marrow examination (aspiration and biopsy): Indicated for severe leukopenia, marked leukocytosis with abnormal cells, or suspected hematologic malignancy; demonstrates cellularity and dysplasia
- Flow cytometry: Analyzes cell characteristics and identifies cell lineages; essential for classifying leukemias and lymphomas
- Cytochemical stains: Myeloperoxidase (MPO), periodic acid-Schiff (PAS), Sudan Black stains to differentiate acute leukemia types
- Chromosomal and molecular studies: Cytogenetics and PCR for specific mutations in suspected hematologic malignancies; Philadelphia chromosome, t(9;22) in CML, t(15;17) in APL
- Infectious disease workup: Blood cultures, viral serology, PCR testing, chest X-ray, or imaging based on clinical presentation
- Biochemical markers: LDH, uric acid, phosphate (elevated in leukemia due to cell turnover), liver and kidney function tests
- Repeat TLC and monitoring frequency: For acute conditions: daily or every 2-3 days; for chronic conditions on treatment: weekly to monthly; for stable patients: quarterly to annually; for cancer patients undergoing chemotherapy: before each cycle and mid-cycle
Fasting Required?
- Fasting Status: NO - Fasting is NOT required for Total Leucocytes Count; test can be performed at any time regardless of food or fluid intake
- Patient preparation requirements: No special dietary restrictions; patient can eat and drink normally; test can be done anytime during the day
- Medication considerations: Continue all regular medications unless specifically instructed otherwise by healthcare provider; inform phlebotomist/laboratory of all current medications, supplements, and recent treatments as they may affect results
- Physical condition recommendations: Avoid excessive physical exertion or strenuous exercise 24 hours before test, rest for 5-10 minutes before blood draw, sit or lie down during specimen collection to prevent syncope (fainting)
- Stress and emotional factors: Minimize stress and anxiety as these may cause temporary elevation in leucocyte count; maintain relaxed state before blood draw
- Timing considerations: Leucocyte counts follow circadian rhythm with lower values in morning and higher in evening; if serial monitoring, try to draw blood at same time each day for consistency; avoid sampling during menstrual period if possible
- Collection method: Blood collected via venipuncture into EDTA (lavender top) tube for complete blood count; typically 1-3 mL of blood required; specimen should be gently mixed and analyzed within 24 hours of collection
- Special circumstances: For hospitalized patients: collect before morning medications; for patients on chemotherapy: collect on specified schedule; emergency samples can be collected anytime without preparation

How our test process works!